LYMPHOBLASTIC LEUKEMIA
Clinical trials for LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients: trial tests Chemo-Free treatment
Disease control TerminatedThis study is testing whether adding a targeted drug called inotuzumab ozogamicin to standard treatment can help adults with a specific, newly diagnosed type of acute lymphoblastic leukemia (Ph+ ALL) achieve a deep remission faster. The goal is to see if this approach leads to be…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test One-Two punch against tough leukemia
Disease control OngoingThis early-stage study is testing whether it's safe and practical to give a pill called dasatinib alongside a specialized cell therapy (Tecartus) for adults whose acute lymphoblastic leukemia has returned or hasn't responded to other treatments. The main goal is to see if patient…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC